About

Mr. Sailer has served as a director of Acurx since October 2018. He is a commercial leader with nearly 30 years of biopharmaceutical experience and currently serves as Senior Vice President, Global Client Solutions at Syneos Health (Nasdaq: SYNH). Previously he was Vice President of Sales and Marketing at Emisphere Technologies (acquired by Novo Nordisk), Vice President of Commercial Operations at New American Therapeutics and at Akrimax Pharmaceuticals, and a member of the executive committee at PDI, a contract commercial organization. He began his career in sales, marketing and sales-management roles in the pharmaceutical and consumer-products divisions of Bristol-Myers Squibb and Bayer Healthcare. Mr. Sailer earned an M.B.A. from Hofstra University and a B.S. in Marketing from Seton Hall University, where he serves as an adjunct graduate professor.

Roles

Acurx Pharmaceuticals, Inc.
Director · Current role
October 2018–present
Syneos Health, Inc.
Senior Vice President, Global Client Solutions
2019 - present
Emisphere Technologies (acquired by Novo Nordisk)
Vice President, Sales & Marketing
2012 - 2019
New American Therapeutics
Vice President, Commercial Operations
2010 - 2012
Akrimax Pharmaceuticals
Vice President, Commercial Operations
2008 - 2010
Bristol-Myers Squibb / Bayer Healthcare
Sales, Marketing & Sales Management roles
—

External Roles

Seton Hall University, Stillman School of Business
Adjunct Professor / Advisory Board, Market Research Center
present

Director Compensation

FY 2024
Fees earned or paid in cash
$45,000
ComponentAnnual cash retainers and committee/leadership fees earned in 2024
Option awards
$22,104
ComponentStock options granted during 2024, ASC 718 grant-date fair value
Total
$67,104

Also at Acurx Pharmaceuticals, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.